Neoleukin Therapeutics - Delisted Stock
Neoleukin Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Neoleukin Therapeutics was actively traded. Please check the stock traded under the symbol NGNE.
Neoleukin Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Neoleukin Therapeutics market risk premium is the additional return an investor will receive from holding Neoleukin Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Neoleukin Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Neoleukin Therapeutics' alpha and beta are two of the key measurements used to evaluate Neoleukin Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
Delisting Warning - NLTX
Neoleukin Therapeutics was delisted
| The entity Neoleukin Therapeutics with a symbol NLTX was delisted from NASDAQ Exchange. Please try Neurogene with a symbol NGNE from now on. Check all delisted instruments accross multiple markets. |
Neoleukin Therapeutics Corporate Directors
Neoleukin Therapeutics corporate directors refer to members of a Neoleukin Therapeutics board of directors. The board of directors generally takes responsibility for the Neoleukin Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Neoleukin Therapeutics' board members must vote for the resolution. The Neoleukin Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Sarah Noonberg | Director | Profile | |
| Cantey Boyd | Director | Profile | |
| Lewis Williams | Director | Profile | |
| Sean Nolan | Director | Profile |
Still Interested in Neoleukin Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |